Skip to main content
Top
Published in: Critical Care 4/2009

01-08-2009 | Commentary

Recently published papers: A review of novel strategies in the prevention of hospital-acquired infections, the ability of intensivists to perform echocardiography, and the benefit of polymyxin B haemoperfusion in abdominal sepsis

Authors: James Hayward, Richard Venn

Published in: Critical Care | Issue 4/2009

Login to get access

Abstract

Chlorhexidine bed baths seem to reduce the incidence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus detected by surveillance cultures. There is also some evidence on the benefit of chlorhexidine mouthwashes in the prevention of ventilator-associated pneumonias. Acid-suppressing drugs increase the incidence of hospital-acquired pneumonias in non-intensive care unit patients, although this association has not been shown in the intensive care setting. Intensivists can be trained to perform basic echocardiography in a short period of time, but their errors could lead to incorrect changes in management. Polymyxin B haemoperfusion was shown in interim analysis to improve patients with abdominal sepsis to such an extent that the EUPHAS randomised controlled trial was halted on ethical grounds, although other authors have criticised this decision.
Literature
1.
go back to reference Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES: The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus , vancomycin-resistant enterococcus and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37: 1858-1865. 10.1097/CCM.0b013e31819ffe6dCrossRefPubMed Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES: The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus , vancomycin-resistant enterococcus and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37: 1858-1865. 10.1097/CCM.0b013e31819ffe6dCrossRefPubMed
2.
go back to reference Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR: Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients. Chest 2009, 135: 1150-1156. 10.1378/chest.08-1321CrossRefPubMed Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR: Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients. Chest 2009, 135: 1150-1156. 10.1378/chest.08-1321CrossRefPubMed
3.
go back to reference Koeman M, Ven AJ, Hak E, Joore HC, Kaasjager K, de Smet AG, Ramsay G, Dormans TP, Aarts LP, de Bel EE, Hustinx WN, Tweel I, Hoepelman AM, Bonten MJ: Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006, 173: 1348-1355. 10.1164/rccm.200505-820OCCrossRefPubMed Koeman M, Ven AJ, Hak E, Joore HC, Kaasjager K, de Smet AG, Ramsay G, Dormans TP, Aarts LP, de Bel EE, Hustinx WN, Tweel I, Hoepelman AM, Bonten MJ: Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006, 173: 1348-1355. 10.1164/rccm.200505-820OCCrossRefPubMed
4.
go back to reference Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V: Randomised controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008, 29: 131-136. 10.1086/526438CrossRefPubMed Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V: Randomised controlled trial and meta-analysis of oral decontamination with 2% chlorhexidine solution for the prevention of ventilator-associated pneumonia. Infect Control Hosp Epidemiol 2008, 29: 131-136. 10.1086/526438CrossRefPubMed
5.
go back to reference National Institute for Health and Clinical Excellence/National Patient Safety Agency: Technical Patient Safety Solutions for Ventilator-associated Pneumonia in Adults. London: NICE; 2008. National Institute for Health and Clinical Excellence/National Patient Safety Agency: Technical Patient Safety Solutions for Ventilator-associated Pneumonia in Adults. London: NICE; 2008.
6.
go back to reference Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 [special article]. Intensive Care Med 2008, 34: 17-60. 10.1007/s00134-007-0934-2PubMedCentralCrossRefPubMed Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 [special article]. Intensive Care Med 2008, 34: 17-60. 10.1007/s00134-007-0934-2PubMedCentralCrossRefPubMed
7.
go back to reference Herzig SJ, Howell MD, Ngo LH, Marcantonio ER: Acid-suppressive medication use and the risk-for hospital acquired pneumonias. JAMA 2009, 301: 2120-2128. 10.1001/jama.2009.722CrossRefPubMed Herzig SJ, Howell MD, Ngo LH, Marcantonio ER: Acid-suppressive medication use and the risk-for hospital acquired pneumonias. JAMA 2009, 301: 2120-2128. 10.1001/jama.2009.722CrossRefPubMed
8.
go back to reference Beaulieu M, Williamson D, Sirois C, Lachaine J: Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit? J Crit Care 2008, 23: 513-518. 10.1016/j.jcrc.2007.11.003CrossRefPubMed Beaulieu M, Williamson D, Sirois C, Lachaine J: Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit? J Crit Care 2008, 23: 513-518. 10.1016/j.jcrc.2007.11.003CrossRefPubMed
9.
go back to reference Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP: Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373: 1874-1882. 10.1016/S0140-6736(09)60658-9CrossRefPubMed Schweickert WD, Pohlman MC, Pohlman AS, Nigos C, Pawlik AJ, Esbrook CL, Spears L, Miller M, Franczyk M, Deprizio D, Schmidt GA, Bowman A, Barr R, McCallister KE, Hall JB, Kress JP: Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 2009, 373: 1874-1882. 10.1016/S0140-6736(09)60658-9CrossRefPubMed
10.
go back to reference Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ: Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009, 35: 854-861. 10.1007/s00134-008-1368-1CrossRefPubMed Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ: Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009, 35: 854-861. 10.1007/s00134-008-1368-1CrossRefPubMed
11.
go back to reference Melamed R, Sprenkle MD, Ulstad VK, Herzog CA, Leatherman JW: Assessment of left ventricular function by intensivists using hand-held echocardiography. Chest 2009, 135: 1416-1419. 10.1378/chest.08-2440CrossRefPubMed Melamed R, Sprenkle MD, Ulstad VK, Herzog CA, Leatherman JW: Assessment of left ventricular function by intensivists using hand-held echocardiography. Chest 2009, 135: 1416-1419. 10.1378/chest.08-2440CrossRefPubMed
12.
go back to reference Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock. The EUPHAS randomised controlled trial. JAMA 2009, 301: 2445-2452. 10.1001/jama.2009.856CrossRefPubMed Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock. The EUPHAS randomised controlled trial. JAMA 2009, 301: 2445-2452. 10.1001/jama.2009.856CrossRefPubMed
13.
go back to reference Kellum JA, Uchino S: International differences in the treatment of sepsis. Are they justified? JAMA 2009, 301: 2496-2497. 10.1001/jama.2009.850CrossRefPubMed Kellum JA, Uchino S: International differences in the treatment of sepsis. Are they justified? JAMA 2009, 301: 2496-2497. 10.1001/jama.2009.850CrossRefPubMed
Metadata
Title
Recently published papers: A review of novel strategies in the prevention of hospital-acquired infections, the ability of intensivists to perform echocardiography, and the benefit of polymyxin B haemoperfusion in abdominal sepsis
Authors
James Hayward
Richard Venn
Publication date
01-08-2009
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2009
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc7992

Other articles of this Issue 4/2009

Critical Care 4/2009 Go to the issue